Voyager Therapeutics, Inc. (VYGR)
3.43
-0.02
(-0.58%)
USD |
NASDAQ |
Sep 01, 16:00
3.39
-0.04
(-1.17%)
After-Hours: 06:29
Voyager Therapeutics Shareholders Equity (Quarterly) : 154.38M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 154.38M |
| March 31, 2026 | 173.67M |
| December 31, 2025 | 196.08M |
| September 30, 2025 | 219.82M |
| June 30, 2025 | 243.94M |
| March 31, 2025 | 272.70M |
| December 31, 2024 | 299.76M |
| September 30, 2024 | 330.31M |
| June 30, 2024 | 335.42M |
| March 31, 2024 | 340.89M |
| December 31, 2023 | 236.32M |
| September 30, 2023 | 176.22M |
| June 30, 2023 | 199.03M |
| March 31, 2023 | 216.96M |
| December 31, 2022 | 59.02M |
| September 30, 2022 | 79.82M |
| June 30, 2022 | 60.05M |
| March 31, 2022 | 75.93M |
| December 31, 2021 | 95.06M |
| September 30, 2021 | 87.42M |
| June 30, 2021 | 110.54M |
| March 31, 2021 | 136.21M |
| December 31, 2020 | 154.32M |
| Date | Value |
|---|---|
| September 30, 2020 | 166.24M |
| June 30, 2020 | 76.88M |
| March 31, 2020 | 79.76M |
| December 31, 2019 | 99.51M |
| September 30, 2019 | 108.16M |
| June 30, 2019 | 118.40M |
| March 31, 2019 | 100.69M |
| December 31, 2018 | 46.45M |
| September 30, 2018 | 65.59M |
| June 30, 2018 | 81.97M |
| March 31, 2018 | 98.29M |
| December 31, 2017 | 134.05M |
| September 30, 2017 | 85.21M |
| June 30, 2017 | 105.29M |
| March 31, 2017 | 122.70M |
| December 31, 2016 | 135.92M |
| September 30, 2016 | 149.12M |
| June 30, 2016 | 155.70M |
| March 31, 2016 | 163.60M |
| December 31, 2015 | 169.07M |
| September 30, 2015 | 101.72M |
| June 30, 2015 | 104.72M |
| March 31, 2015 | 47.88M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 197.75M |
| Total Liabilities (Quarterly) | 43.38M |
| Debt to Equity Ratio | 0.211 |
| Current Ratio | 7.505 |
| Net Debt Paydown Yield | 0.88% |